Health Care Policy
One clinician reflects on the effects of "managed care" on the health care system.
The 115th US Congress is wasting no time considering reforms to the outgoing president's signature healthcare legislation.
The ACA is likely to be partially or fully repealed, though it is uncertain how physician practices and the benefits of the 20 million newly-insured will be affected.
Passage of the Medicare Hospital Readmissions Reduction Program under the Affordable Care Act is associated with a more rapid decrease in 30-day risk-standardized readmission rates.
Providers are still not doing some of the most basic tasks required by the law.
This week, read about the US Surgeon General's report on increased use of e-cigarettes among youths, the Senate's vote on the 21st Century Cures Act, and more.
Many providers still find EMRs vexing, even after all these years.
State Medicaid expansion as part of the Affordable Care Act (ACA) is not associated with length of stay (LOS) or in-hospital mortality among general medicine patients.
Addressable doesn't mean optional: Having an implementation plan can be helpful in case of an audit.
Health insurance premiums under the Affordable Care Act will rise in 2017, analysts and insurance brokers said.
Physicians recently met in Seattle to discuss the difficulties and benefits associated with electronic health records in a third town hall meeting on the subject.
Simplification, consolidation, and real time point-of-care information could address the inefficiencies in the medical billing system.
Given the current political climate and issues of bipartisan concern, 2016 could see certain changes to health care legislation.
Greater transparency is being promoted in clinical research, according to a health policy brief published in Health Affairs.
Hospital reimbursements up and births among young women more often privately covered with the Affordable Care Act, according to 2 research letters.
Implementation of the Affordable Care Act has improved access to care and affordability of care for many adults.
Although Medicaid expansion does not work for many doctors, states are trying to find ways to make it work.
Suggestions include price controls on drugs, hospitals, and doctors.
Comparison with 12 industrialized nations shows that more money is spent, but life expectancy is lowest in the United States.
Improved staffing, electronic medical records, additional inpatient, and aftercare resources help clinicians tackle this issue.
Strategies include educating staff about preferences and processes, using own templates to reduce editing.
One in five workers now have a deductible of $2,000 or more.
Primary care providers mostly positive about impact of health information technology but are divided on ACOs.
Higher numbers of insured leading to more treatment of hypertension, high cholesterol and diabetes.
Compared with survey 5 years earlier, fewer physicians report being satisfied or very satisfied.
Increase due to ACA coverage expansions, faster economic growth and the population aging.
Doctors are encouraged to share stories and email Congress members.
Insurance is major factor in determining receipt of preventive services.
Suggestions include training staff on portal use and showing patients how to use the portal.
Work flow, features and functionality, and technical infrastructure should all be considered.
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified